We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.87B
AUM Growth
+$553M
Cap. Flow
+$147M
Cap. Flow %
3.01%
Top 10 Hldgs %
9.64%
Holding
2,743
New
781
Increased
556
Reduced
401
Closed
657

Sector Composition

Rank Sector Weight
1 Financials 14.84%
2 Healthcare 10.37%
3 Technology 8.45%
4 Consumer Discretionary 7.09%
5 Industrials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLK
1951
DELISTED
Allakos
ALLK
$61.3K ﹤0.01%
13,774
+2,259
+20% +$14.4K
ROVR
1952
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$60.6K ﹤0.01%
+13,371
New +$53.9K
RFACR
1953
DELISTED
RF Acquisition Corp. Rights
RFACR
$60K ﹤0.01%
400,000
PLTNR
1954
DELISTED
Plutonian Acquisition Corp. Rights
PLTNR
$59.6K ﹤0.01%
+322,805
New +$64.2K
TARA icon
1955
Protara Therapeutics
TARA
$233M
$59K ﹤0.01%
18,864
PRTS icon
1956
CarParts.com
PRTS
$52.6M
$57.8K ﹤0.01%
1,082
-131
-11% -$8.3K
PRAX icon
1957
Praxis Precision Medicines
PRAX
$10.1B
$57.6K ﹤0.01%
4,750
+3,046
+179% +$129K
PYPD icon
1958
PolyPid
PYPD
$92.8M
$56.5K ﹤0.01%
4,097
+3,430
+514% +$73K
WINVR
1959
DELISTED
WinVest Acquisition Corp. Right
WINVR
$53.2K ﹤0.01%
590,000
AIBBR
1960
DELISTED
AIB Acquisition Corp Right
AIBBR
$52.5K ﹤0.01%
350,000
ELDN icon
1961
Eledon Pharmaceuticals
ELDN
$270M
$52K ﹤0.01%
22,050
BLACR
1962
DELISTED
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
$51.3K ﹤0.01%
+311,040
New +$48.3K
CSLMR
1963
DELISTED
CSLM Acquisition Corp. Right
CSLMR
$50.4K ﹤0.01%
560,000
PL icon
1964
Planet Labs
PL
$8.46B
$50.3K ﹤0.01%
12,800
-7,200
-36% -$32.2K
GLLIR
1965
DELISTED
Globalink Investment Inc. Rights
GLLIR
$50.2K ﹤0.01%
540,241
-2,609
-0.5% -$160
ANEB
1966
DELISTED
Anebulo Pharmaceuticals
ANEB
$50.2K ﹤0.01%
17,319
AUTL
1967
Autolus Therapeutics
AUTL
$548M
$50.1K ﹤0.01%
27,215
SONN
1968
DELISTED
Sonnet BioTherapeutics
SONN
$49K ﹤0.01%
+774
New +$125K
PSTX
1969
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$48.6K ﹤0.01%
15,792
-1,350
-8% -$8.09K
HTCO
1970
High-Trend International Group
HTCO
$30.5M
$48.2K ﹤0.01%
1,669
ASLN
1971
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$47.7K ﹤0.01%
2,069
DNA icon
1972
Ginkgo Bioworks
DNA
$496M
$46.9K ﹤0.01%
882
+257
+41% +$16.3K
ICCM icon
1973
IceCure Medical
ICCM
$10.9M
$46K ﹤0.01%
1,333
FEXDR
1974
DELISTED
Fintech Ecosystem Development Corp. Right
FEXDR
$46K ﹤0.01%
400,000
TELL
1975
DELISTED
Tellurian Inc.
TELL
$42.8K ﹤0.01%
34,788
-91,566
-72% -$146K

Similar funds

Boothbay Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, Boothbay Fund Management held 2,743 positions worth $4.87B, up 13% from $4.32B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Boothbay Fund Management deployed $147M of net new capital in Q1 2023, opening 781 new positions and adding to 556 existing holdings. Its largest new stake was Abbott: 158,585 shares worth $16.1M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $33.9M trimmed.

  • Boothbay Fund Management's largest Q1 2023 buy was Abbott: 158,585 shares worth $16.1M.
  • Boothbay Fund Management added most to Churchill Capital Corp VII Class A Common Stock in Q1 2023, an estimated $25.2M increase.
  • Boothbay Fund Management's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $33.9M.
  • Boothbay Fund Management fully exited RMG Acquisition Corp. III Class A Ordinary Shares in Q1 2023, selling an estimated $20.5M.
  • Boothbay Fund Management's ten largest holdings make up 9.6% of its $4.87B portfolio in Q1 2023.
  • Boothbay Fund Management opened 781 new positions and closed 657 in Q1 2023.
  • Boothbay Fund Management's portfolio value rose 13% quarter-over-quarter to $4.87B.

Based on Boothbay Fund Management's 13F filing for Q1 2023, filed 15 May 2023.